You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Neovasc closes $5M stock offering to fund heart device development
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
The Market Intelligence Platform
Neovasc Inc. closed an underwritten public offering of 11,111,111 common shares, priced at 45 cents each.
The Richmond, British Columbia-based medical-device maker raised $5 million in gross proceeds that will be used to develop and commercialize its heart devices Neovasc Reducer and Tiara.
Funds from the offering will also be used for general corporate and working capital purposes.
H.C. Wainwright & Co. served as the sole book-running manager for the offering.